Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Toxicol Lett ; 317: 53-58, 2019 Dec 15.
Article in English | MEDLINE | ID: mdl-31560942

ABSTRACT

In 2017, the U.S. Department of Health and Human Services and the White House declared a public health emergency to address the opioid crisis (Hargan, 2017). On average, 192 Americans died from drug overdoses each day in 2017; 130 (67%) of those died specifically because of opioids (Scholl et al., 2019). Since 2013, there have been significant increases in overdose deaths involving synthetic opioids - particularly those involving illicitly-manufactured fentanyl. The U.S. Drug Enforcement Administration (DEA) estimates that 75% of all opioid identifications are illicit fentanyls (DEA, 2018b). Laboratories are routinely asked to confirm which fentanyl or other opioids are involved in an overdose or encountered by first responders. It is critical to identify and classify the types of drugs involved in an overdose, how often they are involved, and how that involvement may change over time. Health care providers, public health professionals, and law enforcement officers need to know which opioids are in use to treat, monitor, and investigate fatal and non-fatal overdoses. By knowing which drugs are present, appropriate prevention and response activities can be implemented. Laboratory testing is available for clinically used and widely recognized opioids. However, there has been a rapid expansion in new illicit opioids, particularly fentanyl analogs that may not be addressed by current laboratory capabilities. In order to test for these new opioids, laboratories require reference standards for the large number of possible fentanyls. To address this need, the Centers for Disease Control and Prevention (CDC) developed the Traceable Opioid Material§ Kits product line, which provides over 150 opioid reference standards, including over 100 fentanyl analogs. These kits were designed to dramatically increase laboratory capability to confirm which opioids are on the streets and causing deaths. The kits are free to U.S based laboratories in the public, private, clinical, law enforcement, research, and public health domains.


Subject(s)
Analgesics, Opioid/analysis , Drug Overdose/diagnosis , Fentanyl/analysis , Opioid-Related Disorders/diagnosis , Reagent Kits, Diagnostic/standards , Substance Abuse Detection/standards , Analgesics, Opioid/classification , Calibration , Drug Overdose/mortality , Fentanyl/analogs & derivatives , Fentanyl/classification , Humans , Opioid-Related Disorders/mortality , Predictive Value of Tests , Reference Standards , Reproducibility of Results , United States/epidemiology
3.
Fed Regist ; 83(230): 61320-3, 2018 Nov 29.
Article in English | MEDLINE | ID: mdl-30497126

ABSTRACT

With the issuance of this final order, the Acting Administrator of the Drug Enforcement Administration maintains the placement of the substances furanyl fentanyl [N-(1- phenethylpiperidin-4-yl)-Nphenylfuran- 2-carboxamide], 4- fluoroisobutyryl fentanyl or parafluoroisobutyryl fentanyl [N-(4- fluorophenyl)-N-(1-phenethylpiperidin- 4-yl)isobutyramide], acryl fentanyl or acryloylfentanyl [N-(1- phenethylpiperidin-4-yl)-Nphenylacrylamide], tetrahydrofuranyl fentanyl [N-(1-phenethylpiperidin-4-yl)- N-phenyltetrahydrofuran-2- carboxamide], and ocfentanil [N-(2- fluorophenyl)-2-methoxy-N-(1- phenethylpiperidin-4-yl)acetamide], including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This scheduling action discharges the United States obligations under the Single Convention on Narcotic Drugs (1961). This action continues to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, furanyl fentanyl, 4- fluoroisobutyryl fentanyl, acryl fentanyl, tetrahydrofuranyl fentanyl, and ocfentanil.


Subject(s)
Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/classification , Furans/classification , Piperidines/classification , Fentanyl/analogs & derivatives , Humans , United States
4.
Fed Regist ; 83(77): 17486-8, 2018 Apr 20.
Article in English | MEDLINE | ID: mdl-30016012

ABSTRACT

With the issuance of this final order, the Administrator of the Drug Enforcement Administration maintains the placement of the substances butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) and U­47700 (3,4-dichloro-N-[2- (dimethylamino)cyclohexyl]-Nmethylbenzamide), including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This scheduling action discharges the United States obligations under the Single Convention on Narcotic Drugs (1961). This action continues to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, butyryl fentanyl and U­ 47700.


Subject(s)
Benzamides/classification , Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/classification , Analgesics, Opioid , Benzamides/adverse effects , Fentanyl/adverse effects , Fentanyl/analogs & derivatives , Humans , Illicit Drugs , United States
5.
Fed Regist ; 83(22): 4580-5, 2018 Feb 01.
Article in English | MEDLINE | ID: mdl-29932604

ABSTRACT

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule seven fentanyl-related substances in schedule I. These seven substances are: N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl fentanyl), N-(4-fluorophenyl)N-(1-phenethylpiperidin-4-yl)butyramide (para-fluorobutyryl fentanyl), N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (para-methoxybutyryl fentanyl), N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (para-chloroisobutyryl fentanyl), N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl), N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopentyl fentanyl), and N-(2- fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil). This action is based on a finding by the Administrator that the placement of these seven synthetic opioids in schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, valeryl fentanyl, para-fluorobutyryl fentanyl, para-methoxybutyryl fentanyl, para-chloroisobutyryl fentanyl, isobutyryl fentanyl, cyclopentyl fentanyl, and ocfentanil.


Subject(s)
Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/classification , Fentanyl/adverse effects , Fentanyl/analysis , Humans , Illicit Drugs/adverse effects , Illicit Drugs/classification , Public Health , United States
6.
Fed Regist ; 83(25): 5188-92, 2018 Feb 06.
Article in English | MEDLINE | ID: mdl-29932611

ABSTRACT

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule fentanyl-related substances that are not currently listed in any schedule of the Controlled Substances Act (CSA) and their isomers, esters, ethers, salts and salts of isomers, esters, and ethers in schedule I. This action is based on a finding by the Administrator that the placement of these synthetic opioids in schedule I is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle fentanyl-related substances.


Subject(s)
Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/classification , Fentanyl/adverse effects , Fentanyl/analogs & derivatives , Humans , Illicit Drugs/adverse effects , Illicit Drugs/classification , Public Health , United States
7.
Fed Regist ; 83(3): 469-72, 2018 Jan 04.
Article in English | MEDLINE | ID: mdl-29319947

ABSTRACT

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioid, -(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide (cyclopropyl fentanyl), and its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers in schedule I. This action is based on a finding by the Administrator that the placement of cyclopropyl fentanyl in schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, cyclopropyl fentanyl.


Subject(s)
Analgesics, Opioid/analysis , Analgesics, Opioid/classification , Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/analogs & derivatives , Fentanyl/classification , Humans , Illicit Drugs/adverse effects , United States
8.
Fed Regist ; 82(206): 49504-8, 2017 Oct 26.
Article in English | MEDLINE | ID: mdl-29091366

ABSTRACT

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioids, N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (ortho-fluorofentanyl or 2-fluorofentanyl), N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide (tetrahydrofuranyl fentanyl), and 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (methoxyacetyl fentanyl), into Schedule I. This action is based on a finding by the Administrator that the placement of ortho-fluorofentanyl, tetrahydrofuranyl fentanyl, and methoxyacetyl fentanyl into Schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, ortho-fluorofentanyl, tetrahydrofuranyl fentanyl, and methoxyacetyl fentanyl.


Subject(s)
Analgesics, Opioid/classification , Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/analysis , Fentanyl/classification , Analgesics, Opioid/adverse effects , Fentanyl/adverse effects , Humans , Illicit Drugs/adverse effects , Illicit Drugs/classification , United States
9.
Fed Regist ; 82(134): 32453-7, 2017 Jul 14.
Article in English | MEDLINE | ID: mdl-28715161

ABSTRACT

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioid, N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryl fentanyl or acryloylfentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters, and ethers, into Schedule I. This action is based on a finding by the Administrator that the placement of acryl fentanyl into Schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, acryl fentanyl.


Subject(s)
Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/classification , Analgesics, Opioid/classification , Fentanyl/analysis , Humans , Illicit Drugs/classification , Illicit Drugs/legislation & jurisprudence , Public Health , United States
10.
Fed Regist ; 82(108): 26349-51, 2017 Jun 07.
Article in English | MEDLINE | ID: mdl-28591974

ABSTRACT

With the issuance of this final order, the Administrator of the Drug Enforcement Administration will maintain the placement of the substance acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide), including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act and is required in order for the United States to discharge its obligations under the Single Convention on Narcotic Drugs, 1961. This action continues to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, acetyl fentanyl.


Subject(s)
Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/analogs & derivatives , Fentanyl/classification , Fentanyl/adverse effects , Humans , Illicit Drugs/adverse effects , Illicit Drugs/legislation & jurisprudence , United States
11.
Fed Regist ; 82(84): 20544-8, 2017 05 03.
Article in English | MEDLINE | ID: mdl-28497944

ABSTRACT

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioid, N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters, and ethers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of 4-fluoroisobutyryl fentanyl into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, 4-fluoroisobutyryl fentanyl.


Subject(s)
Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/classification , Fentanyl/adverse effects , Fentanyl/analogs & derivatives , Humans , Illicit Drugs/classification , Legislation, Drug , Public Health , United States
12.
Fed Regist ; 81(229): 85873-7, 2016 Nov 29.
Article in English | MEDLINE | ID: mdl-27906535

ABSTRACT

The Administrator of the Drug Enforcement Administration is issuing this final order to temporarily schedule the synthetic opioid, N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (furanyl fentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters and ethers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of furanyl fentanyl into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, furanyl fentanyl.


Subject(s)
Analgesics, Opioid/classification , Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/analysis , Fentanyl/classification , Humans , United States
13.
Fed Regist ; 81(166): 58834-40, 2016 Aug 26.
Article in English | MEDLINE | ID: mdl-27568479

ABSTRACT

The Drug Enforcement Administration is placing the substance thiafentanil (4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-[2-(thienyl)ethyl]piperidine), including its isomers, esters, ethers, salts and salts of isomers, esters and ethers as possible, into schedule II of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act, as revised by the Improving Regulatory Transparency for New Medical Therapies Act which was signed into law on November 25, 2015.


Subject(s)
Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/analogs & derivatives , Fentanyl/classification , Analgesics, Opioid/classification , Humans , United States
14.
Fed Regist ; 80(137): 42381-5, 2015 Jul 17.
Article in English | MEDLINE | ID: mdl-26189217

ABSTRACT

The Administrator of the Drug Enforcement Administration is issuing this final order to temporarily schedule the synthetic opioid, N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (acetyl fentanyl), and its optical, positional, and geometric isomers, salts and salts of isomers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of this opioid substance into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, import, export, engage in research, or possess), or propose to handle, acetyl fentanyl.


Subject(s)
Designer Drugs/classification , Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/analogs & derivatives , Fentanyl/classification , Analgesics, Opioid/classification , Humans , Opioid-Related Disorders/epidemiology , Public Health , United States
15.
Rev. Fac. Cienc. Méd. (Quito) ; 19(1/4): 16-20, ene.-dic. 1994. ilus, graf
Article in Spanish | LILACS | ID: lil-178159

ABSTRACT

En pacientes ASA I y II, se evalúa las ventajas que tiene la adición de un narcótico, en este caso el fentanil (100 ug), a la solución del anestésico local (lidoca{ina al 2 por ciento con epinefrina 1:200.000(13cc). La presión arterial sitólica desciende en un 10 por ciento del valor inicial a los 5 minutos retornando a los valores basales aproxidamente a los quince minutos, la frecuencia cardíaca sufre pocas variaciones, sin significación clínica ni estadística. El APGAR del recién nacido tiene una media de (8.5) al primer minuto, y de 9.8) a los cinco minutos. No se reportó complicaciones inherentes a la técnica anestésica durante el seguimiento que se realizó de los niñoa a las 12 y 24 horas...


Subject(s)
Humans , Anesthesia, Epidural , Anesthesia, Epidural/classification , Cesarean Section/classification , Cesarean Section/methods , Fentanyl/administration & dosage , Fentanyl/analysis , Fentanyl/classification , Fentanyl/therapeutic use , Lidocaine/administration & dosage , Lidocaine/analysis , Lidocaine/classification , Lidocaine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...